arrow
Back
D

Donald A. Berry

berry consultants llc

109H-index
686Paper Count
6.1WCitation Count
Published Papers 136
Publication Date
Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
err2025-11-01
err0
errOAAI
errLim, Michael; Berry, Donald; Berry, Nicholas; Colman, Howard; De Groot, John; Ellingson, Benjamin; Gan, Hui; Hyddmark, E. Viktoria; Johnson, Adam; Lassman, Andrew; Mellinghoff, Ingo; Perry, James; Sulman, Erik; Weller, Michael; Wen, Patrick; Cloughesy, Timothy; Network, Gbm Agile Trial
errShare
errSave
Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer
err2024-12-03
err0
errOAAI
errRugo, Hope S.; Campbell, Mike; Yau, Christina; Jo Chien, A.; Wallace, Anne M.; Isaacs, Claudine; Boughey, Judy C.; Han, Hyo S.; Buxton, Meredith; Clennell, Julia L.; Asare, Smita M.; Steeg, Katherine; Wilson, Amy; Singhrao, Ruby; Matthews, Jeffrey B.; Perlmutter, Jane; Fraser Symmans, W.; Hylton, Nola M.; Demichele, Angela M.; Yee, Douglas; Van't Veer, Laura J.; Berry, Donald A.; Esserman, Laura J.
errShare
errSave
EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
err2024-11-11
err0
PREAI
errMellinghoff, Ingo K.; Cloughesy, Timothy; Alexander, Brian; Berry, Donald A.; Buxton, Meredith; Cavenee, Webster; Colman, Howard; de Groot, John; Ellingson, Benjamin M.; Gordon, Gary B.; Lassman, Andrew B.; Lim, Michael; Khasraw, Mustafa; Perry, James; Sulman, Erik P.; Weller, Michael; Wen, Patrick; Yung, W. K. Alfred; Berry, Nicholas; Graves, Todd; Detry, Michelle; Hyddmark, E. M. Viktoria; Johnsson, Adam; Kling, Heather; Mcglothlin, Anna; Powell, Ashley; Untch, Sarah; Aquilanti, Elisa; Blondin, Nicholas; Boulmay, Brian; de la Fuente, Macarena; Drappatz, Jan; Jordan, Justin; Kaley, Thomas J.; Lobbous, Mina; Mikkelsen, Tom; Newton, Herbert; Owen, Scott; Peters, Katherine; Schiff, David; Sherman, Wendy; Weathers, Shiao-Pei; Youssef, Michael; Friend, John; Lee, Eudocia
errShare
errSave
UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
err2024-11-11
err0
PREAI
errLassman, Andrew; Alexander, Brian; Berry, Donald; Berry, Nicholas; Buxton, Meredith; Colman, Howard; Gan, Hui; de Groot, John; de la Fuente, Macarena; Drappatz, Jan; Ducray, Francois; Ellingson, Benjamin; Gordon, Gary; Hyddmark, Emma; Johnson, Adam; Khasraw, Mustafa; Lee, Eudocia; Lim, Michael; Mcglothlin, Anna; Mellinghoff, Ingo; Mikkelsen, Tom; Nghiemphu, Phioanh; Perry, James; Powell, Ashley; Sulman, Erik; Tanner, Krik; Untch, Sarah; Weller, Michael; Wen, Patrick; Wick, Antje; Yung, Alfred; Cloughesy, Timothy
errShare
errSave
Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer
err2024-11-01
err0
errOAAI
errCampbell, Michael J.; Wolf, Denise M.; Yau, Christina; Brown-Swigart, Lamorna; Wulfkuhle, Julie; Gallagher, Isela R.; Zhu, Zelos; Bolen, Jennifer; Vandenberg, Scott; Hoyt, Clifford; Mori, Hidetoshi; Borowsky, Alexander; Sit, Laura; Perlmutter, Jane; Asare, Smita M.; Nanda, Rita; Liu, Minetta C.; Yee, Douglas; Demichele, Angela M.; Hylton, Nola M.; Pusztai, Lajos; Berry, Donald A.; Hirst, Gillian L.; Petricoin, Emanuel F.; van't Veer, Laura; Esserman, Laura
errShare
errSave
KS03.5.A EVALUATION OF VAL-083 IN GBM AGILE, A PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
err2024-10-17
err0
PREAI
errPerry, J. R.; Cloughesy, T.; Berry, D. A.; Buxton, M. B.; Colman, H.; Ellingson, B. M.; Gordon, G. B.; Lassman, A. B.; Lim, M.; Mellinghoff, I. K.; Sulman, E. P.; Weller, M.; Wen, P. Y.; Hyddmark, E.; Mikkelson, T.; Owen, S. P.; Mason, W. P.; Drappatz, J.; Blondin, N. A.; de Groot, J. F.
errShare
errSave
A GLOBAL EXPANSION OF GBM AGILE: A PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
err2024-10-17
err0
PREAI
errWeller, M.; Berry, D.; Blondin, N.; Boulmay, B.; Buxton, M.; Chinot, O.; Colman, H.; de la Fuente, M.; de Groot, J.; Drappatz, J.; Ducray, F.; Ellingson, B.; Galldiks, N.; Gordon, G.; Hau, P.; Hottinger, A.; Hyddmark, V; Khasraw, M.; Kim, L.; Lassman, A.; Lee, E.; Lim, M.; Mellinghoff, I; Mikkelson, T.; Nghiemphu, P.; Perry, J.; Ronellenfitsch, M.; Sulman, E.; Tabatabai, G.; Tanner, K.; Touat, M.; Wen, P. Y.; Wick, A.; Yung, W.; Cloughesy, T.
errShare
errSave
Final results of IMPACT 2, a randomized study evaluating molecular profiling and targeted agents in metastatic cancer at MD Anderson Cancer Center
err2024-09-01
err0
PREAI
errTsimberidou, A. M.; Fu, S.; Hong, D. S.; Piha-Paul, S. A.; Naing, A.; Rodon, J.; Yap, T. A.; Karp, D.; Dumbrava, E. E.; Heymach, J. V.; Ajani, J. A.; Cartwright, C.; Beck, J.; Andersen, C.; Kahle, M.; Vining, D.; Ross, J. S.; Chao, C.; Berry, D. A.; Meric-Bernstam, F.
errShare
errSave
Update on GBM AGILE: A global, phase II/III adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
err2024-09-01
err0
PREAI
errWeller, M.; Berry, D. A.; Blondin, N.; Buxton, M.; Colman, H.; de Groot, J. F.; de la Fuente, M.; Ducray, F.; Ellingson, B.; Gordon, G.; Lassman, A. B.; Lee, E.; Lim, M.; Mellinghoff, I.; Perry, J.; Sulman, E.; Yung, W-K. A.; Wen, P.; Wick, A.; Cloughesy, T.
errShare
errSave
Collaborative Modeling to Compare Different Breast Cancer Screening Strategies
err2024-06-11
err12
PREAI
errTrentham-Dietz, Amy; Chapman, Christina Hunter; Jayasekera, Jinani; Lowry, Kathryn P.; Heckman-Stoddard, Brandy M.; Hampton, John M.; Caswell-Jin, Jennifer L.; Gangnon, Ronald E.; Lu, Ying; Huang, Hui; Stein, Sarah; Sun, Liyang; Gil Quessep, Eugenio J.; Yang, Yuanliang; Lu, Yifan; Song, Juhee; Munoz, Diego F.; Li, Yisheng; Kurian, Allison W.; Kerlikowske, Karla; O'Meara, Ellen S.; Sprague, Brian L.; Tosteson, Anna N. A.; Feuer, Eric J.; Berry, Donald; Plevritis, Sylvia K.; Huang, Xuelin; de Koning, Harry J.; van Ravesteyn, Nicolien T.; Lee, Sandra J.; Alagoz, Oguzhan; Schechter, Clyde B.; Stout, Natasha K.; Miglioretti, Diana L.; Mandelblatt, Jeanne S.
errShare
errSave
Pathological response in resectable non-small cell lung cancer: a systematic literature review and meta-analysis
err2024-03-23
err6
errOAAI
errWaser, Nathalie A.; Quintana, Melanie; Schweikert, Bernd; Chaft, Jamie E.; Berry, Lindsay; Adam, Ahmed; Vo, Lien; Penrod, John R.; Fiore, Joseph; Berry, Donald A.; Goring, Sarah
errShare
errSave
Analysis of Breast Cancer Mortality in the US-1975 to 2019
err2024-01-16
err36
errOAAI
errCaswell-Jin, Jennifer L.; Sun, Liyang P.; Munoz, Diego; Lu, Ying; Li, Yisheng; Huang, Hui; Hampton, John M.; Song, Juhee; Jayasekera, Jinani; Schechter, Clyde; Alagoz, Oguzhan; Stout, Natasha K.; Trentham-Dietz, Amy; Lee, Sandra J.; Huang, Xuelin; Mandelblatt, Jeanne S.; Berry, Donald A.; Kurian, Allison W.; Plevritis, Sylvia K.
errShare
errSave
A phase II trial targeting disseminated dormant tumor cells with hydroxychloroquine, everolimus or the combination to prevent recurrent breast cancer (CLEVER)
err2023-10-01
err2
PREAI
errDeMichele, A.; Clark, A. S.; Bayne, L.; Rohn, K.; Nivar, I.; Wileyto, P.; Berry, L.; DeLuca, S.; Savage, J.; Makhlin, I.; Pan, T. C.; Graves, J.; Belka, G.; Wang, J.; Shih, N.; Berry, D.; Nayak, A.; Feldman, M.; Chodosh, L.
errShare
errSave
UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA.
err2023-09-08
err0
errOAAI
errWeller, M.; Alexander, B.; Berry, D.; Blondin, N.; Buxton, M.; Cavenee, W.; Colman, H.; de Groot, J.; De la Fuente, M.; Ducray, F.; Ellingson, B.; Gordon, G.; Hyddmark, E. M. V.; Khasraw, M.; Lassman, A.; Lee, E.; Lim, M.; Mellinghoff, I.; Mikkelsen, T.; Perry, J.; Sulman, E.; Tanner, K.; Wen, P.; Wick, A.; Yung, A.; Cloughesy, T.
errShare
errSave
GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
err2023-04-14
err0
PREAI
errMellinghoff, Ingo K.; Alexander, Brian; Berry, Donald; Blondin, Nicholas; Buxton, Meredith; Cavenee, Webster; Colman, Howard; de Groot, John; de la Fuente, Macarena I.; Ellingson, Benjamin; Gordon, Gary; Hyddmark, Emma M. V.; Khasraw, Mustafa; Lassman, Andrew; Lee, Eudocia; Li, Wenbin; Lim, Michael; Mikkelsen, Tom; Nelli, Apoorva; Perry, James; Sulman, Erik; Tanner, Kirk; Weller, Michael; Wen, Patrick Y.; Cloughesy, Timothy
errShare
errSave
MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation
err2023-03-27
err219
errOAAI
errYang, Jer-Yen; Zong, Cong S.; Xia, Weiya; Wei, Yongkun; Ali-Seyed, Mohamed; Li, Zheng; Broglio, Kristine; Berry, Donald A.; Hung, Mien-Chie
errShare
errSave
Evaluation of anti-PD-1 Cemiplimab plus anti-LAG-3 REGN3767 in early-stage, high-risk HER2-negative breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL
err2023-03-01
err5
PREAI
errIsaacs, Claudine; Nanda, Rita; Chien, Jo; Trivedi, Meghna S.; Stringer-Reasor, Erica; Vaklavas, Christos; Boughey, Judy C.; Sanford, Amy; Wallace, Anne; Clark, Amy S.; Thomas, Alexandra; Albain, Kathy S.; Kennedy, Laura C.; Sanft, Tara B.; Kalinsky, Kevin; Han, Hyo S.; Williams, Nicole; Arora, Mili; Elias, Anthony; Falkson, Carla; Asare, Smita; Lu, Ruixiao; Pitsouni, Maria; Wilson, Amy; Perlmutter, Jane; Rugo, Hope; Schwab, Richard; Symmans, W. Fraser; Hylton, Nola M.; Van't Veer, Laura; Yee, Douglas; DeMichele, Angela; Berry, Donald; Esserman, Laura J.
errShare
errSave
PD11-01 Evaluation of the PD-1 Inhibitor Cemiplimab in early-stage, high-risk HER2-negative breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL
err2023-03-01
err1
PREAI
errStringer-Reasor, Erica; Shatsky, Rebecca A.; Chien, Jo; Wallace, Anne; Boughey, Judy C.; Albain, Kathy S.; Han, Hyo S.; Nanda, Rita; Isaacs, Claudine; Kalinsky, Kevin; Mitri, Zahi; Clark, Amy S.; Vaklavas, Christos; Thomas, Alexandra; Trivedi, Meghna S.; Lu, Janice; Asare, Smita; Lu, Ruixiao; Pitsouni, Maria; Wilson, Amy; Perlmutter, Jane; Rugo, Hope; Schwab, Richard; Symmans, W. Fraser; Hylton, Nola M.; Van 't Veer, Laura; Yee, Douglas; DeMichele, Angela; Berry, Donald; Esserman, Laura J.
errShare
errSave
Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer's disease
err2022-12-09
err22
errOAAI
errDhadda, Shobha; Kanekiyo, Michio; Li, David; Swanson, Chad J.; Irizarry, Michael; Berry, Scott; Kramer, Lynn D.; Berry, Donald A.
errShare
errSave